rs141105787
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000375985.5(MYLK2):āc.191G>Cā(p.Gly64Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
ENST00000375985.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYLK2 | NM_033118.4 | c.191G>C | p.Gly64Ala | missense_variant | 3/13 | ENST00000375985.5 | NP_149109.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYLK2 | ENST00000375985.5 | c.191G>C | p.Gly64Ala | missense_variant | 3/13 | 1 | NM_033118.4 | ENSP00000365152 | P1 | |
MYLK2 | ENST00000375994.6 | c.191G>C | p.Gly64Ala | missense_variant | 2/12 | 1 | ENSP00000365162 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250472Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135662
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461610Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727100
GnomAD4 genome AF: 0.000171 AC: 26AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74352
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 1 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 64 of the MYLK2 protein (p.Gly64Ala). This variant is present in population databases (rs141105787, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with MYLK2-related conditions. ClinVar contains an entry for this variant (Variation ID: 429230). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYLK2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 14, 2021 | Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 429230; Landrum et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27535533) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at